AUTHOR=De Mel Sanjay , Lee Ainsley Ryan , Tan Joelle Hwee Inn , Tan Rachel Zi Yi , Poon Li Mei , Chan Esther , Lee Joanne , Chee Yen Lin , Lakshminarasappa Satish R. , Jaynes Patrick William , Jeyasekharan Anand D. TITLE=Targeting the DNA damage response in hematological malignancies JOURNAL=Frontiers in Oncology VOLUME=14 YEAR=2024 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1307839 DOI=10.3389/fonc.2024.1307839 ISSN=2234-943X ABSTRACT=

Deregulation of the DNA damage response (DDR) plays a critical role in the pathogenesis and progression of many cancers. The dependency of certain cancers on DDR pathways has enabled exploitation of such through synthetically lethal relationships e.g., Poly ADP-Ribose Polymerase (PARP) inhibitors for BRCA deficient ovarian cancers. Though lagging behind that of solid cancers, DDR inhibitors (DDRi) are being clinically developed for haematological cancers. Furthermore, a high proliferative index characterize many such cancers, suggesting a rationale for combinatorial strategies targeting DDR and replicative stress. In this review, we summarize pre-clinical and clinical data on DDR inhibition in haematological malignancies and highlight distinct haematological cancer subtypes with activity of DDR agents as single agents or in combination with chemotherapeutics and targeted agents. We aim to provide a framework to guide the design of future clinical trials involving haematological cancers for this important class of drugs.